Product Program year 2024 Source: CMS Open Payments

Vantageview

Device Electrophysiology

PDI 05415067014627

Open in the dashboard

General payments

$192,340

590 payments

Research payments

$0

0 payments

Through program year 2024, $192,340 in general payments and $0 in research payments were reported against Vantageview (Electrophysiology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $37,423 58
2023 General $58,872 56
2022 General $96,045 476

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $192,340 590 payments
Top recipients General payments · program year 2024
  1. Mun Hong Interventional Cardiology · Cooperstown, NY $10,375 28% · 9 payments
  2. Gregory Fontana Thoracic Surgery (Cardiothoracic Vascular Surgery) · Thousand Oaks, CA $7,563 20% · 2 payments
  3. Irving David Thoracic Surgery (Cardiothoracic Vascular Surgery) · Aventura, FL $6,650 18% · 4 payments
  4. Mauricio Cohen Interventional Cardiology · Miami, FL $4,331 12% · 4 payments
  5. Scott Hoffman Cardiovascular Disease · Rochester, MN $3,750 10% · 3 payments

The top 5 of 23 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $14,823 40% · 4 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $14,213 38% · 2 practitioners
  3. Cardiovascular Disease Internal Medicine $3,762 10% · 2 practitioners
  4. Surgery $2,613 7% · 1 practitioner
  5. Neurology Psychiatry & Neurology $1,600 4% · 1 practitioner

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Florida $10,981 29% · 2 recipients
  2. New York $10,375 28% · 1 recipient
  3. California $7,563 20% · 1 recipient
  4. Minnesota $5,350 14% · 2 recipients
  5. Pennsylvania $2,613 7% · 1 recipient

The top 5 of 13 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

590 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record